CC
Schedule 13G filing
Coastlands Capital LP disclosed a 6.7% stake in OnKure Therapeutics, Inc. (OKUR)
Coastlands Capital LP reported owning 6.7% of OnKure Therapeutics, Inc. (OKUR) (2,700,000 shares) in a Schedule 13G filed Oct 8, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Oct 8, 2026
- Source
- Schedule 13G
More OKUR insider and Congress trades
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.